Fennec Pharmaceuticals Earnings Preview
Benzinga Insights 1 year ago
Earnings
Fennec Pharmaceuticals (NASDAQ:FENC) will release its quarterly earnings report on Thursday, 2025-08-14. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate Fennec Pharmaceuticals to report an earnings per share (EPS) of $-0.04.
The market awaits Fennec Pharmaceuticals's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
Earnings History Snapshot
Last quarter the company beat EPS by $0.05, which was followed by a 2.31% drop in the share price the next day.
Here's a look at Fennec Pharmaceuticals's past performance and the resulting price change:
| Quarter | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.09 | -0.13 | -0.10 | -0.03 |
| EPS Actual | -0.04 | -0.06 | -0.21 | -0.20 |
| Price Change % | -2.0% | 5.0% | -2.0% | -9.0% |
Stock Performance
Shares of Fennec Pharmaceuticals were trading at $9.24 as of August 12. Over the last 52-week period, shares are up 62.99%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.
To track all earnings releases for Fennec Pharmaceuticals visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.